Hippocratic AI builds the safest healthcare-focused generative AI agents to extend clinical teams and improve patient outcomes across providers, payors, and life sciences.

We develop clinical AI agents (e.g., Polaris 5.0, AI Front Door, Nurse Co‑Pilot) trained on hundreds of millions of de‑identified patient interactions. Our agents support tasks such as patient intake, appointment scheduling, medication identification, vaccination outreach, readmission prevention, RPM adherence, adverse event detection, and study follow‑up. Hippocratic AI’s agents are designed to escalate to human clinicians when appropriate and are not intended to diagnose or prescribe.

Hippocratic AI emphasizes safety and clinical validation: tested with a network of over 7,500 U.S. licensed clinicians on 725K+ test calls and trained on 180M+ clinical interactions. Reported outcomes include reductions in readmissions, improved screening and vaccination rates, higher pre‑charting completion, and strong ROI across deployments.

Trusted by health systems and partners, the platform reports case results such as 30% readmission reduction and up to 12x average ROI in selected use cases.

Hippocratic AI has raised institutional funding (total reported: $404M) from investors including General Catalyst, CapitalG and a16z Bio, and works with healthcare organizations and life sciences partners to deploy clinically focused AI agents.